Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol sedation with ketamine versus alfentanil or remifentanil for cardiac ablation
NL-OMON28894Not yet recruiting
- Sponsor
- Catharina Ziekenhuis
- Start
- Jun 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of propofol, ketamine, alfentanil and remifentanil in Atrial fibrillation (AFib), sponsored by Catharina Ziekenhuis. Primary endpoint: Respiratory stability. Planned start Jun 2015; status: not yet recruiting.
02
Drugs
propofolketaminealfentanilremifentanil
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NL-OMON28894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28894.